Alumis Inc.
Pharmaceutical company · South San Francisco, California, United States · Nasdaq: ALMS
Alumis Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker ALMS. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.
Alumis at a glance
What does Alumis do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $40 million sold (2024).
Frequently asked questions about Alumis
Where is Alumis headquartered?
Alumis Inc. is headquartered in South San Francisco, California, United States.
What does Alumis do?
Alumis Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Alumis a public company?
Yes. Alumis Inc. trades on Nasdaq under the ticker ALMS.
When was Alumis founded?
The earliest incorporation on record for Alumis Inc. is in 2021, according to public company registers.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.